Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage.
10.17479/jacs.2018.8.1.33
- Author:
Jin Bong YE
1
;
Young Hoon SUL
;
Jin Young LEE
;
Seung Je GO
;
Jung Hee CHOI
Author Information
1. Department of Trauma Surgery, Chungbuk National University Hospital, Cheongju, Korea. ssulyh@gmail.com
- Publication Type:Case Report
- Keywords:
Anticoagulants;
Warfarin;
Trauma;
Hemorrhage;
Non-vitamin K-dependent antagonist oral anticoagulants
- MeSH:
Anticoagulants*;
Hand;
Hemorrhage*;
Humans;
Thrombosis;
Vitamin K;
Warfarin*
- From:
Journal of Acute Care Surgery
2018;8(1):33-37
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The traditional drug for anticoagulation in those with a high risk of thrombosis is a vitamin K antagonist, such as warfarin. On the other hand, this drug has several limitations and hemorrhagic complications. Recently, novel or non-vitamin K-dependent antagonist oral anticoagulants (NOACs) have been developed to solve these problems. This paper presents a case of adaptation of NOAC for a warfarin anticoagulated patient with traumatic ongoing hemorrhages with a discussion of the clinical implications of NOAC.
